Two private equity firms can now merge their medical device manufacturing companies

The European Commission has approved the merger of Tecomet and Orchid, two companies that make medical device components. This means Charlesbank and Nordic Capital, the private equity firms that own them, can combine their operations.

This decision allows two major suppliers of parts for medical devices to operate as a single entity in Europe. For device manufacturers, this could mean fewer suppliers to choose from, or a more dominant supplier for critical components. The European Commission decided this would not significantly reduce competition in the market.